Gadeta announces significant progress in advancing pipeline and TEG platform development

/PRNewswire/ -- Gadeta B.V. ('Gadeta'), a clinical-stage company developing innovative, gamma delta (γδ) T-cell receptor (TCR)-based immunotherapies for every...

Related Keywords

Boston ,Massachusetts ,United States ,Netherlands ,Dana Farber Cancer Institute ,Dutch ,Gadetabv Gadeta ,Marcel Zwaal ,Mark Throsby ,Giovanni Mariggi ,Kiadis Pharma ,Beth Israel Deaconess Medical Center ,Mass General Brigham Cancer Care ,Chief Executive Officer ,Kite Pharma ,Supervisory Board ,Gadetabv ,